Latest filings (excl ownership)
6-K
Report of Foreign Private Issuer
18 Dec 23
6-K
Notice of Extraordinary General Meeting
29 Nov 23
D
$500.00 k in equity, sold $500.00 k, 1 investor
25 Oct 23
25-NSE
Exchange delisting
12 Oct 23
6-K
Securities Purchase Agreement
10 Oct 23
6-K
Report of Foreign Private Issuer
22 Sep 23
6-K
Report of Foreign Private Issuer
13 Sep 23
6-K
Notice of Annual General Meeting
25 Aug 23
6-K
Report of Foreign Private Issuer
25 Aug 23
6-K
Report of Foreign Private Issuer
25 Aug 23
6-K
Report of Foreign Private Issuer
23 Aug 23
6-K
G Medical Innovations Will Provide Services to Veterans and Military Personnel by Partnering With Resilient Support Services
17 Aug 23
6-K
G Medical Innovations’ CEO Issues Update to Shareholders, August 2023
7 Aug 23
F-1
Registration statement (foreign)
27 Jul 23
S-8
Registration of securities for employees
5 Jul 23
6-K
Report of Foreign Private Issuer
1 Jun 23
6-K
G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
19 May 23
6-K
G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Hearings Panel’s Decision to Grant Exception for Continued Listing
16 May 23
20-F
2022 FY
Annual report (foreign)
16 May 23
NT 20-F
Notice of late annual filing (foreign)
2 May 23
6-K
Report of Foreign Private Issuer
18 Apr 23
6-K
G Medical Innovations Holdings Ltd. Announces Pricing of Public Offering
4 Apr 23
424B4
Prospectus supplement with pricing info
4 Apr 23
EFFECT
Notice of effectiveness
3 Apr 23
6-K
Report of Foreign Private Issuer
29 Mar 23
FWP
Free writing prospectus
27 Mar 23
F-1/A
Registration statement (foreign) (amended)
27 Mar 23
6-K
G Medical Innovations and Micare Path Announce Joint Collaboration to Provide Innovative Remote Patient Monitoring Solutions Globally
27 Mar 23
CORRESP
Correspondence with SEC
27 Mar 23
CORRESP
Correspondence with SEC
27 Mar 23
F-1/A
Registration statement (foreign) (amended)
24 Mar 23
6-K
Report of Foreign Private Issuer
23 Mar 23
FWP
Free writing prospectus
28 Feb 23
F-1/A
Registration statement (foreign) (amended)
28 Feb 23
6-K
Report of Foreign Private Issuer
28 Feb 23
6-K
G Medical Innovations Holdings Ltd Announces Nasdaq Staff Listing Determination; Plans to Request Hearing
17 Feb 23
6-K
Report of Foreign Private Issuer
16 Feb 23
6-K
G Medical Innovations announces receipt of patent from USPTO for vital signs sensors
13 Feb 23
UPLOAD
Letter from SEC
6 Feb 23
F-1
Registration statement (foreign)
1 Feb 23
Latest ownership filings
SC 13D/A
Rubini Jonathan Brian
12 Apr 24
SC 13D/A
Rubini Jonathan Brian
7 Feb 24
SC 13D/A
Rubini Jonathan Brian
24 Oct 23
SC 13D/A
Geva Yacov
25 Aug 23
SC 13G/A
BIGGER CAPITAL FUND L P
18 Aug 23
SC 13G/A
JPMORGAN CHASE & CO
8 Aug 23
SC 13G/A
AWM Investment Company, Inc.
10 May 23
SC 13D/A
Geva Yacov
13 Apr 23
SC 13G
AWM Investment Company, Inc.
11 Apr 23
SC 13G
BIGGER CAPITAL FUND L P
6 Apr 23
4
Change in insider ownership
4 Apr 23
3
Initial statement of insider ownership
4 Apr 23
SC 13D
Rubini Jonathan Brian
3 Feb 23
SC 13G
JPMORGAN CHASE & CO
31 Jan 23
SC 13D
Geva Yacov
30 Jan 23
SC 13G
Geva Yacov
22 Feb 22